Comparisons of resistance of CF and Non-CF pathogens to hydrogen peroxide and hypochlorous acid oxidants in vitro

BMC Microbiology

Volumn 11, Issue , 2011, Pages

  Bonvillain, Ryan W ^a,b   Painter, Richard G ^a   Ledet, Elisa M ^a   Wang, Guoshun ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cystic Fibrosis; Hydrogen Peroxide; Hypochlorous Acid; Microbicidal; Neutrophils; Oxidants

Indexed keywords

ADENOSINE TRIPHOSPHATE; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; OXIDIZING AGENT;

ARTICLE; BACTERIAL VIABILITY; BURKHOLDERIA CEPACIA; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CYSTIC FIBROSIS; ESCHERICHIA COLI; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; STAPHYLOCOCCUS AUREUS; ANTIBIOTIC RESISTANCE; BACTERIUM; DRUG EFFECT; ENERGY METABOLISM; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY;

BACTERIA (MICROORGANISMS); BURKHOLDERIA CEPACIA; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ADENOSINE TRIPHOSPHATE; BACTERIA; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; ENERGY METABOLISM; HUMANS; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; MICROBIAL SENSITIVITY TESTS; OXIDANTS;

EID: 79956202470     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-11-112     Document Type: Article

References (30)

1. Cystic fibrosis: molecular biology and therapeutic implications. FS Collins, Science 1992 256 5058 774 779 10.1126/science.1375392 1375392
2. Cystic Fibrosis. MJ Welsh BW Ramsey F Accurso G Cutting, Metabolic and Molecular Basis of Interited Disease New York: McGraw-Hill, Scriver CR, 8 2001 5121 5188
3. Cystic fibrosis. PB Davis M Drumm MW Konstan, Am J Respir Crit Care Med 1996 154 5 1229 1256 8912731 (Pubitemid 26391164)
4. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. RT Sadikot TS Blackwell JW Christman AS Prince, Am J Respir Crit Care Med 2005 171 11 1209 1223 10.1164/rccm.200408-1044SO 15695491 (Pubitemid 40740727)
5. Cystic Fibrosis Foundation Patient Rigestry: 2009 Annual Data Report. Foundation CF, http://www.cff.org/UploadedFiles/research/ClinicalResearch/ Patient-Registry-Report-2009.pdf
6. Pathophysiology and management of pulmonary infections in cystic fibrosis. RL Gibson JL Burns BW Ramsey, Am J Respir Crit Care Med 2003 168 8 918 951 10.1164/rccm.200304-505SO 14555458 (Pubitemid 37267172)
7. Myeloperoxidase: friend and foe. SJ Klebanoff, J Leukoc Biol 2005 77 5 598 625 10.1189/jlb.1204697 15689384 (Pubitemid 40628741)
8. How human neutrophils kill and degrade microbes: an integrated view. WM Nauseef, Immunol Rev 2007 219 88 102 10.1111/j.1600-065X.2007.00550.x 17850484 (Pubitemid 47390004)
9. Neutrophil microbicides induce a pathogen survival response in community-associated methicillin-resistant Staphylococcus aureus. AM Palazzolo-Ballance ML Reniere KR Braughton DE Sturdevant M Otto BN Kreiswirth EP Skaar FR DeLeo, J Immunol 2008 180 1 500 509 18097052
10. Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing. CC Winterbourn MB Hampton JH Livesey AJ Kettle, J Biol Chem 2006 281 52 39860 39869 10.1074/jbc.M605898200 17074761 (Pubitemid 46041789)
11. Involvement of superoxide and myeloperoxidase in oxygen-dependent killing of Staphylococcus aureus by neutrophils. MB Hampton AJ Kettle CC Winterbourn, Infect Immun 1996 64 9 3512 3517 8751892 (Pubitemid 26298668)
12. CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. RG Painter VG Valentine NA Lanson Jr K Leidal Q Zhang G Lombard C Thompson A Viswanathan WM Nauseef G Wang, Biochemistry 2006 45 34 10260 10269 10.1021/bi060490t 16922501 (Pubitemid 44384801)
13. The role of chloride anion and CFTR in killing of Pseudomonas aeruginosa by normal and CF neutrophils. RG Painter RW Bonvillain VG Valentine GA Lombard SG LaPlace WM Nauseef G Wang, J Leukoc Biol 2008 83 6 1345 1353 10.1189/jlb.0907658 18353929 (Pubitemid 351960313)
14. CFTR-mediated halide transport in phagosomes of human neutrophils. RG Painter L Marrero GA Lombard VG Valentine WM Nauseef G Wang, J Leukoc Biol 2010 87 933 942 10.1189/jlb.1009655 20089668
15. Manual of Clinical Microbiology. PR Murray EJ Baron JH Jorgensen ML Landry MA Pfaller, Washington, DC: ASM Press 9 2007 1
16. The inhibition of bacterial growth by hypochlorous acid. Possible role in the bactericidal activity of phagocytes. SM McKenna KJ Davies, Biochem J 1988 254 3 685 692 2848494
17. General mechanism for the bacterial toxicity of hypochlorous acid: abolition of ATP production. WC Barrette Jr DM Hannum WD Wheeler JK Hurst, Biochemistry 1989 28 23 9172 9178 10.1021/bi00449a032 2557918 (Pubitemid 19283487)
18. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. JL Burns RL Gibson S McNamara D Yim J Emerson M Rosenfeld P Hiatt K McCoy R Castile AL Smith BW Ramsey, J Infect Dis 2001 183 3 444 452 10.1086/318075 11133376 (Pubitemid 32105604)
19. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. M Rosenfeld RL Gibson S McNamara J Emerson JL Burns R Castile P Hiatt K McCoy CB Wilson A Inglis A Smith TR Martin BW Ramsey, Pediatr Pulmonol 2001 32 5 356 366 10.1002/ppul.1144 11596160 (Pubitemid 33015652)
20. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. MS Muhlebach PW Stewart MW Leigh TL Noah, Am J Respir Crit Care Med 1999 160 1 186 191 10390398 (Pubitemid 29326086)
21. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis. DS Armstrong K Grimwood JB Carlin R Carzino A Olinsky PD Phelan, Pediatr Pulmonol 1996 21 5 267 275 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K 8726151 (Pubitemid 26159822)
22. Bacterial biofilms: an emerging link to disease pathogenesis. MR Parsek PK Singh, Annu Rev Microbiol 2003 57 677 701 10.1146/annurev.micro.57.030502. 090720 14527295 (Pubitemid 37392958)
23. Microbiology of sputum from patients at cystic fibrosis centers in the United States. JL Burns J Emerson JR Stapp DL Yim J Krzewinski L Louden BW Ramsey CR Clausen, Clin Infect Dis 1998 27 1 158 163 10.1086/514631 9675470 (Pubitemid 28334435)
24. Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study. BC Kahl A Duebbers G Lubritz J Haeberle HG Koch B Ritzerfeld M Reilly E Harms RA Proctor M Herrmann G Peters, J Clin Microbiol 2003 41 9 4424 4427 10.1128/JCM.41.9. 4424-4427.2003 12958283 (Pubitemid 37099721)
25. Bactericidal activity against Pseudomonas aeruginosa is acquired by cultured human monocyte-derived macrophages after uptake of myeloperoxidase. M Mathy-Hartert G Deby-Dupont P Melin M Lamy C Deby, Experientia 1996 52 2 167 174 10.1007/BF01923364 8608819 (Pubitemid 26067574)
26. Neutrophil bleaching of GFP-expressing staphylococci: probing the intraphagosomal fate of individual bacteria. J Schwartz KG Leidal JK Femling JP Weiss WM Nauseef, J Immunol 2009 183 4 2632 2641 10.4049/jimmunol.0804110 19620311
27. Mechanism of the bactericidal action of myeloperoxidase: increased permeability of the Escherichia coli cell envelope. HJ Sips MN Hamers, Infect Immun 1981 31 1 11 16 6260658 (Pubitemid 11136049)
28. Effects of the putative neutrophil-generated toxin, hypochlorous acid, on membrane permeability and transport systems of Escherichia coli. JM Albrich JH Gilbaugh KB Callahan JK Hurst, J Clin Invest 1986 78 1 177 184 10.1172/JCI112548 3013936 (Pubitemid 16068197)
29. Viability and metabolic capability are maintained by Escherichia coli, Pseudomonas aeruginosa, and Streptococcus lactis at very low adenylate energy charge. WC Barrette Jr DM Hannum WD Wheeler JK Hurst, J Bacteriol 1988 170 8 3655 3659 3136145
30. Subunit sites of oxidative inactivation of Escherichia coli F1-ATPase by HOCl. DM Hannum WC Barrette Jr JK Hurst, Biochem Biophys Res Commun 1995 212 3 868 874 10.1006/bbrc.1995.2049 7626123